Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1836 of 6351
-
Radiation after targeted therapy may keep skin cancer away
Disease control Recruiting nowLocally advanced basal cell carcinoma (BCC) are large BCCs or BCCs located in areas subject to functional and aesthetic risk following surgery or radiotherapy. In these particular situations, surgery and radiotherapy are sometimes not appropriate, and Sonic Hedgehog inhibitors (S…
Phase 2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a daily powder cut wheezing attacks in toddlers?
Disease control OngoingThis study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheezing
Phase 2 • Sponsor: OM Pharma SA • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Kenya pharmacy PrEP trial: a new way to fight HIV?
Prevention CompletedA cluster-randomized control trial (cRCT) testing different cost-sharing models for the delivery of HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) services at private pharmacies in Kenya. The goal is to assess the effect of different pharmacy-based PrEP/P…
Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Real-world data shows REBYOTA™ may stop c. diff from coming back
Prevention CompletedThis is a prospective observational cohort study designed to collect data on patients who received REBYOTA™ for the prevention of rCDI in the routine care setting. As all data collected for this study are observational, the decision to prescribe REBYOTA™ is at the treating physic…
Sponsor: Ferring Pharmaceuticals • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New pill for scarred lungs shows promise in early trial
Disease control CompletedThe goal of this clinical trial is to learn about INS018\_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018\_055 orally administered for up to 12 weeks in adult subjects with IPF compared to placebo…
Phase 2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a common wound dressing trigger allergic skin reactions?
Knowledge-focused CompletedThe aim of this multi-surgeon, single institution study is to prospectively evaluate the incidence of allergic contact dermatitis (ACD) following application of AQUACEL Ag, a silver-containing hydrofiber dressing, in total hip and knee arthroplasty patients. Arthroplasty-naïve pa…
Phase 4 • Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New procedure aims to stop debilitating headaches from spinal fluid leaks
Disease control Recruiting nowThe purpose of this research is to determine the efficacy of paraspinal vein embolization for treatment of digital subtraction myelography (DSM) or CT myelography (CTM) confirmed cerebrospinal fluid (CSF)-venous fistulas so that researchers can inform the development and design o…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Experimental immune cell therapy targets tough leukemia
Disease control Stopped earlyThis is a single group, Phase 1, single-arm, dose escalation study to determine the candidate dose(s), and evaluate safety, tolerability, and preliminary anti-tumor activity of SAR445419 administered after fludarabine and cytarabine conditioning for the treatment of relapsed or r…
Phase 1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New antibody shows promise against rare liver infection
Disease control CompletedThis is a multicenter, randomized, controlled, open-label, Phase IIb study of HH-003 injection, HH-003 injection is a monoclonal antibody targeting Hepatitis B virus. This study aims to assess efficacy and safety in subjects with chronic hepatitis delta virus infection.
Phase 2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New imaging agent could spot hidden myeloma cells
Diagnosis Recruiting nowThis phase I trial tests the safety of \[89Zr\]DFO-YS5 positron emission tomography (PET) imaging and how well it works to detect CD46 positive cancer cells in patients with multiple myeloma. \[89Zr\]DFO-YS5 is an imaging agent called a radiopharmaceutical tracer. A radiopharmace…
Phase 1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Can a Phone-Based program help people with chronic pain cut back on opioids?
Disease control OngoingThis project aims to test simultaneously the effectiveness of telemedicine and collaborative management (TCM) vs. TCM plus Cooperative Pain Education and Self-Management (COPES) on patient level outcomes and the impact of site-tailored Implementation Facilitation to work toward l…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New blood test screening targets hidden cancer in black communities
Diagnosis OngoingThis project will pilot the expansion of the existing Taussig Outreach Program's community outreach and patient navigation model to study the multiple myeloma (MM) screening program. This involves analyzing community reception, screening program methods, reasons patients decided …
Sponsor: Case Comprehensive Cancer Center • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden prostate cancer
Diagnosis CompletedPhase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared (NIR) fluorescence imaging, for identification of prostate cancer during robotic-assisted radical prostatectomy (RARP) with (extended) pelvic lymph node dissection ((e)PLND) using the da…
Phase 2 • Sponsor: Intuitive Surgical • Aim: Diagnosis
Last updated Jun 26, 2026 13:38 UTC
-
New disc implant aims to ease pain after herniated disc surgery
Disease control PausedThis study is a First in Human, prospective, multi-center clinical study intended to collect safety and performance information for the Spinal Stabilization Technologies PerQdisc® Nucleus Replacement System and procedure concurrently following a successful discectomy using a mini…
Sponsor: Spinal Stabilization Technologies • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New program aims to cut heart risks in psoriasis patients
Prevention OngoingThe goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.
Sponsor: University of Pennsylvania • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Peer support could boost opioid treatment in rural areas
Disease control Recruiting nowThe purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved are…
Sponsor: University of Maryland, College Park • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for kidney transplant patients battling BK virus
Disease control OngoingBK virus infection is one of the causes of renal allograft loss in the current era. Reduction of immunsuppression is the only intervention that prooved to be effective in treating of BK virus in kidney transplant recipient. However, there are evidences from retrospective and pros…
Sponsor: King Chulalongkorn Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can a simple dressing save lives? new trial targets ECMO infections
Disease control CompletedThe Dressing-ECMO trial is a prospective, open-label, multicenter, controlled trial randomizing patients who received percutaneous ECMO to cannula chlorhexidine-impregnated dressing vs standard dressing. The study goal is to determine if cannula chlorhexidine-impregnated dressing…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
VR meditation may help smokers kick the habit
Symptom relief Recruiting nowInvestigators seek to propose a non-drug therapeutic alternative, namely a mindfulness meditation protocol based on virtual reality training in order to induce progressive modifications of various indicators of craving. The study hypothesis is that the practice of mindfulness me…
Sponsor: Centre Hospitalier Henri Laborit • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can less be more? new study tests a gentler dosing schedule for advanced bladder cancer drug
Disease control OngoingThis is a non-randomized two arm open-label phase 2 pilot study in adult subjects with locally advanced or metastatic urothelial cancer. The study will investigate an alternative administration schedule of EV given as monotherapy and in combination with pembrolizumab.
Phase 2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC